Investigation Overview
Nov. 1, 2012 (Shareholders Foundation) -- An investigation on behalf of investors of ABIOMED, Inc. (NASDAQ:ABMD) shares over potential securities laws violations by ABIOMED, Inc. and certain of its directors and officers in connection the Company's marketing and labeling of the Impella 2.5. The investigation by a law firm focuses on possible claims on behalf of purchasers of the se...
You must register (for free) or login to view the entire investigation.